{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:08:48Z","timestamp":1791094128573,"version":"4.1.0"},"reference-count":33,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,7,14]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The present study focuses on a large family with an X-linked immunodeficiency in which there are variable clinical and laboratory phenotypes, including recurrent viral and bacterial infections, hypogammaglobulinemia, Epstein-Barr virus\u2013driven lymphoproliferation, splenomegaly, colitis, and liver disease. Molecular and genetic analyses revealed that affected males were carriers of a hypomorphic hemizygous mutation in XIAP (XIAPG466X) that cosegregated with a rare polymorphism in CD40LG (CD40 ligandG219R). These genes are involved in the X-linked lymphoproliferative syndrome 2 and the X-linked hyper-IgM syndrome, respectively. Single expression of XIAPG466X or CD40LG219R had no or minimal effect in vivo, although in vitro, they lead to altered functional activities of their gene products, which suggests that the combination of XIAP and CD40LG mutations contributed to the expression of clinical manifestations observed in affected individuals. Our report of a primary X-linked immunodeficiency of oligogenic origin emphasizes that primary immunodeficiencies are not caused by a single defective gene, which leads to restricted manifestations, but are likely to be the result of an interplay between several genetic determinants, which leads to more variable clinical phenotypes.<\/jats:p>","DOI":"10.1182\/blood-2011-01-328849","type":"journal-article","created":{"date-parts":[[2011,5,5]],"date-time":"2011-05-05T01:01:32Z","timestamp":1304557292000},"page":"252-261","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":45,"title":["Human X-linked variable immunodeficiency caused by a hypomorphic mutation in XIAP in association with a rare polymorphism in CD40LG"],"prefix":"10.1182","volume":"118","author":[{"given":"St\u00e9phanie","family":"Rigaud","sequence":"first","affiliation":[{"name":"Laboratoire du D\u00e9veloppement Normal et Pathologique du Syst\u00e8me Immunitaire, Inserm, Unit\u00e9 768, H\u00f4pital Necker Enfants-Malades, Paris, France;"},{"name":"Universit\u00e9 Paris-Descartes, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Lopez-Granados","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Sib\u00e9ril","sequence":"additional","affiliation":[{"name":"Laboratoire du D\u00e9veloppement Normal et Pathologique du Syst\u00e8me Immunitaire, Inserm, Unit\u00e9 768, H\u00f4pital Necker Enfants-Malades, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Gloire","sequence":"additional","affiliation":[{"name":"Laboratoire du D\u00e9veloppement Normal et Pathologique du Syst\u00e8me Immunitaire, Inserm, Unit\u00e9 768, H\u00f4pital Necker Enfants-Malades, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Lambert","sequence":"additional","affiliation":[{"name":"Centre d'\u00e9tude des D\u00e9ficits Immunitaires, H\u00f4pital Necker Enfants-Malades, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Lenoir","sequence":"additional","affiliation":[{"name":"Laboratoire du D\u00e9veloppement Normal et Pathologique du Syst\u00e8me Immunitaire, Inserm, Unit\u00e9 768, H\u00f4pital Necker Enfants-Malades, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Synaeve","sequence":"additional","affiliation":[{"name":"Laboratoire du D\u00e9veloppement Normal et Pathologique du Syst\u00e8me Immunitaire, Inserm, Unit\u00e9 768, H\u00f4pital Necker Enfants-Malades, Paris, France;"},{"name":"Universit\u00e9 Paris-Descartes, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Stacey","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Fugger","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Stephan","sequence":"additional","affiliation":[{"name":"Unit\u00e9 d'H\u00e9matologie et d'Oncologie P\u00e9diatrique, H\u00f4pital Nord, Centre Hospitalier Universitaire, Saint-Etienne, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Fischer","sequence":"additional","affiliation":[{"name":"Laboratoire du D\u00e9veloppement Normal et Pathologique du Syst\u00e8me Immunitaire, Inserm, Unit\u00e9 768, H\u00f4pital Necker Enfants-Malades, Paris, France;"},{"name":"Universit\u00e9 Paris-Descartes, Paris, France;"},{"name":"National Reference Centre for Primary Immune Deficiencies, Centre de R\u00e9f\u00e9rence des D\u00e9ficits Immunitaries H\u00e9r\u00e9ditaires, H\u00f4pital Necker Enfants-Malades, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Capucine","family":"Picard","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Descartes, Paris, France;"},{"name":"Centre d'\u00e9tude des D\u00e9ficits Immunitaires, H\u00f4pital Necker Enfants-Malades, Assistance Publique\u2013H\u00f4pitaux de Paris (AP-HP), Paris, France;"},{"name":"National Reference Centre for Primary Immune Deficiencies, Centre de R\u00e9f\u00e9rence des D\u00e9ficits Immunitaries H\u00e9r\u00e9ditaires, H\u00f4pital Necker Enfants-Malades, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Durandy","sequence":"additional","affiliation":[{"name":"Laboratoire du D\u00e9veloppement Normal et Pathologique du Syst\u00e8me Immunitaire, Inserm, Unit\u00e9 768, H\u00f4pital Necker Enfants-Malades, Paris, France;"},{"name":"Universit\u00e9 Paris-Descartes, Paris, France;"},{"name":"National Reference Centre for Primary Immune Deficiencies, Centre de R\u00e9f\u00e9rence des D\u00e9ficits Immunitaries H\u00e9r\u00e9ditaires, H\u00f4pital Necker Enfants-Malades, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Chapel","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Latour","sequence":"additional","affiliation":[{"name":"Laboratoire du D\u00e9veloppement Normal et Pathologique du Syst\u00e8me Immunitaire, Inserm, Unit\u00e9 768, H\u00f4pital Necker Enfants-Malades, Paris, France;"},{"name":"Universit\u00e9 Paris-Descartes, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"7115","key":"2019111808281216900_B1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature05257","article-title":"XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome.","volume":"444","author":"Rigaud","year":"2006","journal-title":"Nature"},{"issue":"3","key":"2019111808281216900_B2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1046\/j.1365-2141.2002.03851.x","article-title":"X-linked lymphoproliferative disease: clinical, diagnostic and molecular perspective.","volume":"119","author":"Gaspar","year":"2002","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111808281216900_B3","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1182\/blood-2010-07-298372","article-title":"Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1\/SAP-deficiency) versus type 2 (XLP-2\/XIAP-deficiency).","volume":"117","author":"Pachlopnik Schmid","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2019111808281216900_B4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/cdd.2009.81","article-title":"XIAP as a ubiquitin ligase in cellular signaling.","volume":"17","author":"Galban","year":"2010","journal-title":"Cell Death Differ"},{"issue":"10","key":"2019111808281216900_B5","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/sj.embor.7400795","article-title":"Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family.","volume":"7","author":"Eckelman","year":"2006","journal-title":"EMBO Rep"},{"issue":"7","key":"2019111808281216900_B6","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1182\/blood-2010-01-256099","article-title":"XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease.","volume":"116","author":"Marsh","year":"2010","journal-title":"Blood"},{"issue":"5","key":"2019111808281216900_B7","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1182\/blood.V98.5.1321","article-title":"Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome.","volume":"98","author":"Morra","year":"2001","journal-title":"Blood"},{"issue":"12","key":"2019111808281216900_B8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s00431-002-1083-9","article-title":"Mutations of the X-linked lymphoproliferative disease gene SH2D1A mimicking common variable immunodeficiency.","volume":"161","author":"Soresina","year":"2002","journal-title":"Eur J Pediatr"},{"issue":"1\u20132","key":"2019111808281216900_B9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jneuroim.2009.10.012","article-title":"An atypical case of X-linked lymphoproliferative disease revealed as a late cerebral lymphoma.","volume":"218","author":"Hervier","year":"2010","journal-title":"J Neuroimmunol"},{"issue":"1","key":"2019111808281216900_B10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1365-2249.2001.01599.x","article-title":"X-linked lymphoproliferative disease: three atypical cases.","volume":"126","author":"Nistala","year":"2001","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"2019111808281216900_B11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000135702","article-title":"Sequence analysis of BIRC4\/XIAP in male patients with common variable immunodeficiency.","volume":"147","author":"Salzer","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"key":"2019111808281216900_B12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.immunol.25.022106.141651","article-title":"Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules.","volume":"25","author":"Ma","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"2019111808281216900_B13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.immunol.021908.132649","article-title":"Primary B cell immunodeficiencies: comparisons and contrasts.","volume":"27","author":"Conley","year":"2009","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"2019111808281216900_B14","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1182\/blood.V92.7.2421","article-title":"Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome.","volume":"92","author":"Seyama","year":"1998","journal-title":"Blood"},{"issue":"3","key":"2019111808281216900_B15","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1073\/pnas.91.3.1099","article-title":"CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.","volume":"91","author":"Farrington","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2019111808281216900_B16","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/blood-2003-12-4420","article-title":"Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome.","volume":"105","author":"Lee","year":"2005","journal-title":"Blood"},{"issue":"41","key":"2019111808281216900_B17","doi-asserted-by":"crossref","first-page":"29936","DOI":"10.1074\/jbc.M703911200","article-title":"Substrate modification with lysine 63-linked ubiquitin chains through the UBC13-UEV1A ubiquitin-conjugating enzyme.","volume":"282","author":"Petroski","year":"2007","journal-title":"J Biol Chem"},{"issue":"6639","key":"2019111808281216900_B18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/40901","article-title":"X-linked IAP is a direct inhibitor of cell-death proteases.","volume":"388","author":"Deveraux","year":"1997","journal-title":"Nature"},{"issue":"37","key":"2019111808281216900_B19","doi-asserted-by":"crossref","first-page":"22782","DOI":"10.1074\/jbc.271.37.22782","article-title":"Differential intrinsic enzymatic activity of Syk and Zap-70 protein-tyrosine kinases.","volume":"271","author":"Latour","year":"1996","journal-title":"J Biol Chem"},{"issue":"6","key":"2019111808281216900_B20","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.4049\/jimmunol.158.6.2576","article-title":"Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression.","volume":"158","author":"Durandy","year":"1997","journal-title":"J Immunol"},{"issue":"1","key":"2019111808281216900_B21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1172\/JCI118389","article-title":"A single strand conformation polymorphism study of CD40 ligand: efficient mutation analysis and carrier detection for X-linked hyper IgM syndrome.","volume":"97","author":"Lin","year":"1996","journal-title":"J Clin Invest"},{"issue":"1","key":"2019111808281216900_B22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1365-2567.2000.00943.x","article-title":"A polymorphic CD40 ligand (CD154) molecule mediates CD40-dependent signalling but interferes with the ability of soluble CD40 to functionally block CD154:CD40 interactions.","volume":"99","author":"Barnhart","year":"2000","journal-title":"Immunology"},{"issue":"5","key":"2019111808281216900_B23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ng.367","article-title":"A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation.","volume":"41","author":"Tarpey","year":"2009","journal-title":"Nat Genet"},{"issue":"3","key":"2019111808281216900_B24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/protein\/gzm004","article-title":"The structural basis of hyper IgM deficiency: CD40L mutations.","volume":"20","author":"Thusberg","year":"2007","journal-title":"Protein Eng Des Sel"},{"issue":"part 3","key":"2019111808281216900_B25","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1042\/bj20030583","article-title":"Identification of ubiquitination sites on the X-linked inhibitor of apoptosis protein.","volume":"373","author":"Shin","year":"2003","journal-title":"Biochem J"},{"key":"2019111808281216900_B26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.biochem.70.1.503","article-title":"Mechanisms underlying ubiquitination.","volume":"70","author":"Pickart","year":"2001","journal-title":"Annu Rev Biochem"},{"issue":"12","key":"2019111808281216900_B27","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/ni.1676","article-title":"Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK.","volume":"9","author":"Zarnegar","year":"2008","journal-title":"Nat Immunol"},{"issue":"12","key":"2019111808281216900_B28","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/ni.1678","article-title":"Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling.","volume":"9","author":"Vallabhapurapu","year":"2008","journal-title":"Nat Immunol"},{"issue":"1","key":"2019111808281216900_B29","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","article-title":"Molecular mechanism and function of CD40\/CD40L engagement in the immune system.","volume":"229","author":"Elgueta","year":"2009","journal-title":"Immunol Rev"},{"issue":"7","key":"2019111808281216900_B30","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1091\/mbc.e08-01-0107","article-title":"The RING domain of cIAP1 mediates the degradation of RING-bearing inhibitor of apoptosis proteins by distinct pathways.","volume":"19","author":"Cheung","year":"2008","journal-title":"Mol Biol Cell"},{"issue":"45","key":"2019111808281216900_B31","doi-asserted-by":"crossref","first-page":"16182","DOI":"10.1073\/pnas.0502828102","article-title":"Determination of cell survival by RING-mediated regulation of inhibitor of apoptosis (IAP) protein abundance.","volume":"102","author":"Silke","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"2019111808281216900_B32","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/eji.1830260732","article-title":"Accessory signaling by CD40 for T cell activation: induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-gamma production.","volume":"26","author":"Peng","year":"1996","journal-title":"Eur J Immunol"},{"issue":"5589","key":"2019111808281216900_B33","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1126\/science.1072615","article-title":"A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory.","volume":"297","author":"Bourgeois","year":"2002","journal-title":"Science"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/2\/252\/1343521\/zh802811000252.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/2\/252\/1343521\/zh802811000252.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T16:09:54Z","timestamp":1686067794000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/2\/252\/28492\/Human-Xlinked-variable-immunodeficiency-caused-by"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,14]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,7,14]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-01-328849","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,14]]}}}